Impax Laboratories Receives a Hold from BMO Capital

BMO Capital analyst Gary Nachman reiterated a Hold rating on Impax Laboratories (NASDAQ: IPXL) yesterday and set a price target of $16. The company’s shares closed yesterday at $16.70. According to TipRanks.com, More »

Analysts Offer Insights on Technology Companies: Synchronoss Technologies (NASDAQ: SNCR) and Salesforce.com (NYSE: CRM)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Synchronoss Technologies (NASDAQ: SNCR) and Salesforce.com (NYSE: CRM). Synchronoss Technologies (NASDAQ: SNCR) In a report More »